✓
Open
20 Mar 2026
✓
Close
24 Mar 2026
3
Allotment
—
✓
Listing
Mon, Mar 30, 2026
Price Band
₹117 to ₹124
Issue Size
23,50,000 shares (agg. up to ₹29 Cr)
Lot Size
1,000 Shares
Listing Date
Mon, Mar 30, 2026
Latest GMP
₹0
Est. Gain
0%
✦ AI Insight
GMP Trend
30-03-2026₹0Est. ₹124+0%
29-03-2026₹0Est. ₹124+0%
28-03-2026₹0Est. ₹124+0%
Live Subscription
| Category | Subscription (times) |
|---|---|
| Total | 1.35x |
Restated Financials (₹ Cr.)
| Period Ended | 31 Oct 2025 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Assets | 45.57 | 39.98 | 22.68 |
| Total Income | 36.93 | 58.54 | 27.66 |
| Profit After Tax | 6.06 | 8.61 | 2.93 |
| EBITDA | 6.51 | 9.09 | 5.26 |
| NET Worth | 36.47 | 30.42 | 15.06 |
| Reserves and Surplus | 30.04 | 23.98 | 9.95 |
| Total Borrowing | 4.81 | 5.05 | 2.86 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Accretion Nutraveda Ltd. | SME | ₹24.77 Cr | ₹129 | 26.27 | ₹191.20 | +48.22% | ₹279.00 |
| KRM Ayurveda Ltd. | SME | ₹77.49 Cr | ₹135 | 17.32 | ₹180.70 | +33.85% | ₹289.75 |
| Curis Lifesciences Ltd. | SME | ₹27.52 Cr | ₹128 | 12.44 | ₹141.00 | +10.16% | ₹198.80 |
| Aptus Pharma Ltd. | SME | ₹13.02 Cr | ₹70 | 11.29 | ₹84.84 | +21.20% | ₹333.35 |
| Asston Pharmaceuticals Ltd. | SME | ₹27.56 Cr | ₹123 | 17.83 | ₹124.95 | +1.59% | ₹110.00 |
| Influx Healthtech Ltd. | SME | ₹58.57 Cr | ₹96 | 13.04 | ₹126.20 | +31.46% | ₹283.70 |
| Astonea Labs Ltd. | SME | ₹37.67 Cr | ₹135 | 27.36 | ₹135.65 | +0.48% | ₹289.00 |
| Accretion Pharmaceuticals Ltd. | SME | ₹29.75 Cr | ₹101 | 21.29 | ₹82.95 | -17.87% | ₹210.00 |
| Corona Remedies Ltd. | Mainboard | ₹655.37 Cr | ₹1062 | 43.47 | ₹1,438.40 | +35.44% | ₹2,093.20 |
| Rubicon Research Ltd. | Mainboard | ₹1,377.50 Cr | ₹485 | 55.75 | ₹628.20 | +29.53% | ₹1,860.60 |
| Amanta Healthcare Ltd. | Mainboard | ₹126.00 Cr | ₹126 | 34.59 | ₹141.75 | +12.50% | ₹201.86 |
| Anlon Healthcare Ltd. | Mainboard | ₹121.03 Cr | ₹91 | 17.67 | ₹91.73 | +0.80% | ₹15.61 |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Setting up of Research and Development (R&D) Centre at Revenue City Survey No. RV1/NA/61/1/50, Moje, Manda, Tal. Umargam, Dist. Valsad, Gujarat | 12.68 |
| 2 | Product Registration in International Markets and Product Development for sale in international markets | 2.99 |
| 3 | Funding for Marketing and Promotional Activities | 1.66 |
| 4 | To Meet Working Capital Requirements | 8.00 |
| 5 | General Corporate Purposes | 0.25 |
| 6 | Issue Expenses | 3.57 |
| Total | 29.14 |
About Speciality Medicines IPO
Updated on Aug 5, 2026
Contact Details
Speciality Medicines Ltd. Address913, One World West, S.No.396, FP 119Village-Vejalpur, Ahmadabad CityAhmedabad, Gujarat, 380051+91 22 4604 5344investors.grievances@specialitymedicine.comVisit Website